Bank of Nova Scotia
COCH icon

Bank of Nova Scotia’s Envoy Medical COCH Stock Holding History

Bank of Nova Scotia’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-69,999
Closed -$707K – 1149
2022
Q4 		$707K Hold
69,999
– – ﹤0.01% 865
2022
Q3 		$688K Hold
69,999
– – ﹤0.01% 895
2022
Q2 		$686K Hold
69,999
– – ﹤0.01% 946
2022
Q1 		$684K Hold
69,999
– – ﹤0.01% 993
2021
Q4 		$682K Buy
+69,999
New +$683K ﹤0.01% 1058

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bank of Nova Scotia's COCH Position: Q1 2023 in Review

Bank of Nova Scotia sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 69,999 shares — an estimated $707K sold.

Bank of Nova Scotia first reported a position in COCH in Q4 2021 and held it in 5 quarters. The position peaked at $707K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Bank of Nova Scotia reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 69,999 Envoy Medical shares in Q1 2023, an estimated $707K.
  • Bank of Nova Scotia first reported a position in Envoy Medical in Q4 2021 and held it in 5 quarters.
  • Bank of Nova Scotia's Envoy Medical position peaked at $707K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Bank of Nova Scotia's 13F filing for Q1 2023, filed 11 May 2023.